We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Ares Acquisition Corporation | NYSE:AAC | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.79 | 0 | 01:00:00 |
Files Declaration by LA County Chief Medical Examiner-Coroner Contradicting Prosecution and Grand Jury Testimony
AAC Holdings, Inc. (NYSE: AAC) announced that, as expected, it filed motions to dismiss the indictment in the California case on January 22, 2016. In its motions, the Company highlighted many reasons that it believes a dismissal of all charges is warranted, including:
The Company also disclosed that the Chief Medical Examiner-Coroner for Los Angeles County, Dr. Mark A. Fajardo, signed a declaration that was also filed with the Court that contradicts claims made by the California Attorney General’s office and testimony provided by paid experts in grand jury testimony. Dr. Fajardo previously served as Chief Forensic Pathologist of the Riverside County Sheriff-Coroner and performed the autopsy on the individual who died of natural causes in 2010. In a ruling on January 22, the Court ordered the complete coroner’s file to be produced to the Court.
From this declaration, the Company noted the following points from Dr. Fajardo:
Michael Cartwright, Chairman and Chief Executive Officer of AAC Holdings, noted, “We are thankful that Dr. Fajardo has come forward with his public declaration stating that the decedent died of hypertensive cardiovascular disease and that he stands by his initial opinion. Clearly, we believe his testimony should have been heard by the grand jury. We look forward to the judicial process as we have complete faith in the American judicial system.”
About American Addiction Centers
American Addiction Centers is a leading provider of inpatient substance abuse treatment services. We treat clients who are struggling with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues. We operate 18 substance abuse treatment facilities. Located throughout the United States, these facilities are focused on delivering effective clinical care and treatment solutions. For more information, please find us at AmericanAddictionCenters.org or follow us on Twitter @AAC_Tweet. Copies of the Company’s legal filings can be found at AACtheTruth.com.
Forward Looking Statements
This release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are made only as of the date of this release. In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “may,” “potential,” “predicts,” “projects,” “should,” “will,” “would,” and similar expressions intended to identify forward-looking statements, although not all forward-looking statements contain these words. Forward-looking statements may include information concerning AAC Holdings, Inc.’s (collectively with its subsidiaries; “Holdings” or the “Company”) possible or assumed future results of operations, including descriptions of Holdings’ revenues, profitability, outlook and overall business strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from the information contained in the forward-looking statements. These risks, uncertainties and other factors include, without limitation: (i) our inability to operate our facilities; (ii) our reliance on our sales and marketing program to continuously attract and enroll clients; (iii) a reduction in reimbursement rates by certain third-party payors for inpatient and outpatient services and point of care and definitive lab testing; (iv) our failure to successfully achieve growth through acquisitions and de novo expansions; (v) uncertainties regarding the timing of the closing of acquisitions; (vi) the possibility that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of acquisitions; (vii) our failure to achieve anticipated financial results from contemplated acquisitions; (viii) a disruption in our ability to perform definitive drug testing services; (ix) maintaining compliance with applicable regulatory authorities, licensure and permits to operate our facilities and lab; (x) a disruption in our business related to the recent indictment of certain of our subsidiaries and current and former employees; (xi) our inability to agree on conversion and other terms for the balance of convertible debt; (xii) our inability to meet our covenants in the loan documents; (xiii) our inability to obtain senior lender consent to exceed the current $50 million limit in unsecured subordinated debt; (xiv) our inability to integrate newly acquired facilities; (xv) a disruption to our business and reputational and potential economic risks associated with the civil securities claims brought by shareholders; and (xvi) general economic conditions, as well as other risks discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K, and other filings with the Securities and Exchange Commission. As a result of these factors, we cannot assure you that the forward-looking statements in this release will prove to be accurate. Investors should not place undue reliance upon forward looking statements.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160125005546/en/
Investor Contact:SCR PartnersTripp Sullivan, 615-760-1104IR@contactAAC.comorMedia Contact:AAC Holdings, Inc.Cynthia Johnson, 615-587-7728Mediarequest@contactAAC.com
1 Year Ares Acquisition Chart |
1 Month Ares Acquisition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions